… Head of Biomarkers ProQR Therapeutics is a NASDAQ-listed biotechnology company … with an office in and Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease and change lives. A team of 180+ enthusiastic ProQRians from all walks of life and more than 30 different …
… Head of Clinical Quantitative Science ProQR Therapeutics is a NASDAQ-listed biotechnology company … with an office in and Cambridge, Massachusetts, USA. At ProQR, we are on a mission to edit RNA, treat disease and … with statistical software and modeling tools (e.g., R, SAS, Python , Bayesian frameworks). Proven success in …
ProQR will host an investor webcast on May 9, 2024 at 8:00 am EDT with members of the ProQR Management Team to highlight the data being presented in the ASGCT 2024 poster session and will also conduct an analyst Q&A session.
This virtual event on March 29, 2023 featured presentations by ProQR Management on the company's proprietary Axiomer® RNA editing technology platform, detailed the initial pipeline targets, and provided guidance on the advancement of programs toward the clinic. ProQR also reported its 2022 year-end financials and the extension of its cash runway guidance.
The 2021 annual general meeting (AGM) of shareholders of ProQR Therapeutics
will take place on Wednesday, May 19, 2021, at 16:00 hours CET/10:00am EDT.
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
